NEW YORK (GenomeWeb News) – The US Department of Defense said recently that PerkinElmer Genetics has been awarded a maximum $9.7 million modification exercising the second option year of a one-year base contract with four one-year option periods for newborn screening services. "The modification is a firm-fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity, performance-based service contract," according to DoD. May 6, 2014 is the performance completion date. PerkinElmer did not reply to a message seeking additional information.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.